European guidelines on achalasia: united European gastroenterology and European society of neurogastroenterology and motility recommendations

RAB Oude Nijhuis, G Zaninotto… - United European …, 2020 - journals.sagepub.com
Introduction Achalasia is a primary motor disorder of the oesophagus characterised by
absence of peristalsis and insufficient lower oesophageal sphincter relaxation. With new …

The 2018 ISDE achalasia guidelines

G Zaninotto, C Bennett, G Boeckxstaens… - Diseases of the …, 2018 - academic.oup.com
Achalasia is a relatively rare primary motor esophageal disorder, characterized by absence
of relaxations of the lower esophageal sphincter and of peristalsis along the esophageal …

Clinical management of pediatric achalasia

M van Lennep, MP van Wijk, TIM Omari… - Expert review of …, 2018 - Taylor & Francis
Introduction Achalasia is a rare esophageal motility disorder. Much of the literature is based
on the adult population. In adults, guidance of therapeutic approach by manometric findings …

[HTML][HTML] European Guideline on Achalasia–UEG and ESNM recommendations

RABO Nijhuis, G Zaninotto, S Roman… - United European …, 2020 - ncbi.nlm.nih.gov
Methods Guidelines were established by a working group of representatives from United
European Gastroenterology, European Society of Neurogastroenterology and Motility …

[HTML][HTML] Evaluating the non-conventional achalasia treatment modalities

F Tustumi - Frontiers in Medicine, 2022 - frontiersin.org
Introduction Achalasia is a primary esophageal dysmotility disorder. Despite the high
volume of studies addressing the conventional treatments for achalasia, few are debated …

[HTML][HTML] Pharmacotherapy for the management of achalasia: Current status, challenges and future directions

A Nassri, Z Ramzan - World Journal of Gastrointestinal …, 2015 - ncbi.nlm.nih.gov
This article reviews currently available pharmacological options available for the treatment
of achalasia, with a special focus on the role of botulinum toxin (BT) injection due to its …

[HTML][HTML] Assessment of pneumatic balloon dilation in patients with symptomatic relapse after failed Heller myotomy: a single center experience

M Amani, N Fazlollahi, S Shirani… - Middle East journal of …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Although Heller myotomy is one of the most effective treatments for
achalasia, it may be associated with early or late symptom relapse in some patients …

Laparoscopic esophageal myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized controlled trials

R Baniya, S Upadhaya, J Khan, SK Subedi… - Clinical and …, 2017 - Taylor & Francis
Background Achalasia is a primary esophageal motility disorder of unknown etiology
associated with abnormalities in peristalsis and lower esophageal sphincter relaxation. The …

[HTML][HTML] Ethanolamine oleate versus botulinum toxin in the treatment of idiopathic achalasia

J Mikaeli, AK Veisari, N Fazlollahi… - … Publication of the …, 2015 - ncbi.nlm.nih.gov
Background Botulinum toxin (BT) injection reduces lower esophageal sphincter pressure
and alleviates symptoms in idiopathic achalasia (IA). Ethanolamine oleate (EO) has also …

[HTML][HTML] Management of primary achalasia: The role of endoscopy

M Luján-Sanchis, P Suárez-Callol… - World Journal of …, 2015 - ncbi.nlm.nih.gov
Achalasia is an oesophageal motor disorder which leads to the functional obstruction of the
lower oesophageal sphincter (LES) and is currently incurable. The main objective of all …